
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>La décision d’une vitrectomie dans une endophtalmie repose encore actuellement sur les résultats de l’Endophthalmitis Vitrectomy Study (EVS). Les circonstances qui justifient sa réalisation en urgence dans une endophtalmie sont uniquement une acuité visuelle limitée à des perceptions lumineuses. Bien entendu d’autres conditions sont nécessaires : milieux cornéens clairs, logistique adaptée à la réalisation d’une vitrectomie en urgence (bloc opératoire équipé). L’ensemble de ces limites fait qu’en pratique la vitrectomie est souvent repoussée dans les 3 à 5 jours qui suivent la présentation initiale en jugeant avant tout le caractère évolutif sous traitements antibiotiques et anti-inflammatoire. Toutefois la vitrectomie reste limitée pour éviter les tractions vitréennes périphériques mal contrôlées pouvant être responsables de décollement de la rétine. L’autre indication, plus tardive, correspond aux traitements des opacités vitréennes résiduelles ou des complications maculaires comme les membranes épirétiniennes.
The decision to perform a vitrectomy in a case of endophthalmitis is mainly based on the Endophthalmitis Vitrectomy Study (EVS) conclusions. An emergency vitrectomy is helpful when the baseline visual acuity is lower than hand motion perceptions. However, various coexisting conditions should be considered: clear media and the availability of an operating room dedicated to emergency surgery. These limitations lead to a frequent delay in vitrectomy to assess the progression of the initial presentation after treatment with antibiotics and anti-inflammatory agents. However, in these cases, the vitrectomy will remain restricted to the center of the vitreous cavity to limit peripheral retinovitreal traction favoring retinal detachment. Vitrectomy performed to treat the residual vitreous opacity or macular complications such as epiretinal membranes, subject to even greater delay, is another indication.
Clinical Trials as Topic, Endophthalmitis, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Time Factors, epiretinal membrane, vitrectomy, Anti-Inflammatory Agents, Retinal Detachment, Visual Acuity, Epiretinal Membrane, Combined Modality Therapy, Anti-Bacterial Agents, retinal detachment, Postoperative Complications, endophthalmitis, [SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs, Vitrectomy, Humans, Drug Therapy, Combination
Clinical Trials as Topic, Endophthalmitis, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Time Factors, epiretinal membrane, vitrectomy, Anti-Inflammatory Agents, Retinal Detachment, Visual Acuity, Epiretinal Membrane, Combined Modality Therapy, Anti-Bacterial Agents, retinal detachment, Postoperative Complications, endophthalmitis, [SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs, Vitrectomy, Humans, Drug Therapy, Combination
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
